Search Count: 483
![]() |
Hca450-21.1 Fab And Gd2 Complex
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2026-06-17 Classification: RECOMBINATION Ligands: PO4 |
Organism: Mus musculus
Method: X-RAY DIFFRACTION
Release Date: 2026-06-17
Ligands: PO4
![]() |
Structure Of Ptp1B Complexed With Difluoromethylphosphonate Inhibitor Compound 2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2026-05-27 Classification: HYDROLASE/INHIBITOR Ligands: A1C3A |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-05-27
Ligands: A1C3A
![]() |
Structure Of Ptp1B Complexed With Difluoromethylphosphonate Inhibitor Compound 10
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.51 Å Release Date: 2026-05-27 Classification: HYDROLASE/INHIBITOR Ligands: A1C3B |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-05-27
Ligands: A1C3B
![]() |
Structure Of Ptp1B Complexed With Difluoromethylphosphonate Inhibitor Compound 15
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2026-05-27 Classification: HYDROLASE/INHIBITOR Ligands: A1C3C, DMS |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-05-27
Ligands: A1C3C, DMS
![]() |
Structure Of Ptp1B Complexed With Difluoromethylphosphonate Inhibitor Compound 30
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2026-05-27 Classification: HYDROLASE/INHIBITOR Ligands: A1C3D |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-05-27
Ligands: A1C3D
![]() |
Crystal Structure Of A2A Adenosine Receptor A2Ar-Bril In Complex With Compound50
Organism: Homo sapiens, Escherichia coli
Method: X-RAY DIFFRACTION Resolution:2.59 Å Release Date: 2026-05-20 Classification: MEMBRANE PROTEIN |
Organism: Homo sapiens, Escherichia coli
Method: X-RAY DIFFRACTION
Release Date: 2026-05-20
![]() |
Crystal Structure Of Gmppnp Bound Kras-Y71H In Complex With Rbd Domain Of Craf(Raf1)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.68 Å Release Date: 2026-05-20 Classification: ONCOPROTEIN Ligands: GNP, MG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-05-20
Ligands: GNP, MG
![]() |
Crystal Structure Of Gmppnp Bound Kras G12C In Complex With Cypa And Rmc-4791
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.57 Å Release Date: 2026-05-20 Classification: ONCOPROTEIN Ligands: MG, GNP, A1CYT |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-05-20
Ligands: MG, GNP, A1CYT
![]() |
Sars-Cov-2 Nsp14 With 1-(4-Methylphenyl)-2-(2-Methylsulfanyl-4,5-Dihydroimidazol-1-Yl)Ethanone
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.29 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1I9H, DMS, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1I9H, DMS, ZN
![]() |
Sars-Cov-2 Nsp14 With 2,5-Dichlorothiophene-3-Sulfonamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1AYN, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1AYN, DMS, ZN, PO4
![]() |
Sars-Cov-2 Nsp14 With Ethyl 2-(1H-Indol-3-Yl)Acetate
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1I9J, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1I9J, DMS, ZN, PO4
![]() |
Sars-Cov-2 Nsp14 With 2,5-Dimethylpyrazol-3-Amine
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1I9K, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1I9K, DMS, ZN, PO4
![]() |
Sars-Cov-2 Nsp14 With N-Methyl-1-(2-Methyl-5-Phenylpyrazol-3-Yl)Methanamine
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: X6W, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: X6W, DMS, ZN, PO4
![]() |
Sars-Cov-2 Nsp14 With 1-Benzofuran-3-Carboxylic Acid
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1JA8, DMS, EPE, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1JA8, DMS, EPE, ZN, PO4
![]() |
Sars-Cov-2 Nsp14 With 2-(1H-Indol-3-Yl)Ethanol
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: ZCW, DMS, PO4, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: ZCW, DMS, PO4, ZN
![]() |
Sars-Cov-2 Nsp14 With Benzenesulfonamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: FB2, EPE, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: FB2, EPE, DMS, ZN, PO4
![]() |
Sars-Cov-2 Nsp14 With 5-Chlorothiophene-2-Sulfonamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: GOL, 8K2, EPE, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: GOL, 8K2, EPE, DMS, ZN, PO4
![]() |
Sars-Cov-2 Nsp14 With 3,4-Dichlorobenzenesulfonamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1JBC, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1JBC, DMS, ZN, PO4
![]() |
Sars-Cov-2 Nsp14 With 2,5-Dichloro-4-Methylthiophene-3-Sulfonamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1JBA, DMS, EPE, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1JBA, DMS, EPE, ZN, PO4
![]() |
Sars-Cov-2 Nsp14 With 2,5-Dichlorothiophene-3-Sulfonic Acid
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.14 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1JA9, DMS, ZN, PO4 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-04-29
Ligands: A1JA9, DMS, ZN, PO4
